Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cytochrome P-450 CYP3A5 Inhibitors

Known as: Inhibitors, CYP3A5, P450 CYP3A5 Inhibitors, CYP3A5 Inhibitors 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM Meta-analyses and large cohort studies provide confusing results on the association of the CYP3A5 6986A>G allelic variant and… Expand
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
2017
2017
BACKGROUND Tacrolimus is an immunosuppressive agent, used in the remission induction therapy of ulcerative colitis (UC). AIMS… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 3
2017
2017
Tacrolimus is a potent but expensive first-line immunosuppressant, thus solutions to reduce tacrolimus consumption while maintain… Expand
  • table 2
2016
2016
PURPOSE Peripheral neuropathy is a frequent vincristine-induced adverse effect. Vincristine is a substrate of P-glycoprotein and… Expand
2012
2012
We evaluated the hypothesis that cytochrome P450 3A5 (CYP3A5) expression can affect intrarenal tacrolimus accumulation… Expand
2011
2011
El cancer de mama es un problema de salud publica en Mexico y en el mundo. Las enzimas citocromo P450 metabolizan la mayoria de… Expand
Highly Cited
2011
Highly Cited
2011
AIM Recently a SNP of the gene encoding P450 oxidoreductase (POR*28; rs1057868C>T) has been associated with increased in vivo… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Highly Cited
2011
Highly Cited
2011
BACKGROUND The effect of potentially relevant genetic polymorphisms, CYP3A5 6986A>G and ABCB1 3435C>T, on Tacrolimus… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2009
2009
Introduction Tamoxifen therapy reduces the risk of recurrence and prolongs the survival of oestrogen-receptor-positive patients… Expand
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Highly Cited
2006
Highly Cited
2006
IntroductionTamoxifen therapy reduces the risk of recurrence and prolongs the survival of oestrogen-receptor-positive patients… Expand
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2